Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.30994 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2024. Written by Sydney Peng and 12 co-authors. Institution: Allina Health Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA. Major MEDLINE topics: ST Elevation Myocardial Infarction, Stroke, Percutaneous Coronary Intervention, Coronary Thrombosis. Cited 2 times so far (Crossref); 18 references. Funded by: The authors are grateful for the philanthropic support of our generous anonymous donors, and the philanthropic support of Drs. Mary Ann and Donald A Sens; Mrs.….
Abstract (original language)
Background
The use of the Indigo CAT RX Aspiration System (Penumbra Inc.) during percutaneous coronary intervention has received limited study.
Methods
We retrospectively examined the clinical, angiographic, and procedural characteristics, outcomes, and follow‐up of patients who underwent mechanical aspiration thrombectomy with the Indigo CAT RX system (Penumbra Inc.) at a large tertiary care hospital between January 2019 and April 2023.
Results
During the study period, 83 patients (85 lesions) underwent thrombectomy with the Indigo CAT RX. Mean patient age was 64.9 ± 14.48 years and 31.2% were women. The most common presentations were ST‐segment elevation myocardial infarction (MI) (66.2%) and non‐ST‐segment elevation MI (26.5%). A final thrombolysis in MI flow grade of 3 and final myocardial blush grade of 3 were achieved in 76% and 46% of the cases, respectively. Technical success was achieved in 88.9% of the cases that included Indigo CAT RX treatment only, compared with 57.1% of the cases that also included manual aspiration. There were no device‐related serious adverse events. At 30‐day postprocedure, the incidence of major adverse cardiac events (composite of cardiovascular death, recurrent MI, cardiogenic shock, new or worsening New York Heart Association Class IV heart failure, stroke) was 8.5%: 1.3% stroke (postprocedure, in‐hospital), 1.3% MI, 6.1% cardiac death, and 7.5% developed cardiogenic shock.
Conclusions
Use of the Indigo CAT RX system is associated with high technical success and acceptable risk of complications, including stroke.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Allina Health Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
ORCID profiles: Sydney Peng, Athanasios Rempakos, Olga C Mastrodemos, Michaella Alexandrou, Salman Allana, Ahmed Al-Ogaili, Emmanouil S Brilakis
Funding
- The authors are grateful for the philanthropic support of our generous anonymous donors, and the philanthropic support of Drs. Mary Ann and Donald A Sens; Mrs.…
Cite
APA
Peng, S., Rempakos, A., Mastrodemos, O. C., Rangan, B. V., Alexandrou, M., Allana, S., Al-Ogaili, A., Mutlu, D., Karacsonyi, J., Bergstedt, S., Khalid, M. S., Stanberry, L., & Brilakis, E. S. (2024). Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30994
Vancouver
Peng S, Rempakos A, Mastrodemos OC, Rangan BV, Alexandrou M, Allana S, et al. Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.30994
BibTeX
@article{Peng2024,
author = {Peng, Sydney and Rempakos, Athanasios and Mastrodemos, Olga C and Rangan, Bavana V and Alexandrou, Michaella and Allana, Salman and Al-Ogaili, Ahmed and Mutlu, Deniz and Karacsonyi, Judit and Bergstedt, Seth and Khalid, Muhmmad S and Stanberry, Larissa and Brilakis, Emmanouil S},
title = {Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.30994}
}
EUVIMED